109 related articles for article (PubMed ID: 1951478)
1. Atypical structured glomerular deposits: an immunohistochemical study.
Nakajima M; Hewitson TD; Mathews DC; Forbes I; Kincaid-Smith P
Am J Nephrol; 1991; 11(2):151-6. PubMed ID: 1951478
[TBL] [Abstract][Full Text] [Related]
2. In situ complement activation in porcine membranoproliferative glomerulonephritis type II.
Jansen JH; Høgåsen K; Harboe M; Hovig T
Kidney Int; 1998 Feb; 53(2):331-49. PubMed ID: 9461093
[TBL] [Abstract][Full Text] [Related]
3. Membranoproliferative glomerulonephritis with isolated C3 deposits: case report and literature review.
Darouich S; Goucha R; Jaafoura MH; Zekri S; Kheder A; Ben Maiz H
Ultrastruct Pathol; 2011 Feb; 35(1):42-6. PubMed ID: 21265634
[TBL] [Abstract][Full Text] [Related]
4. Lupus nephritis: correlation between light, electron microscopic and immunofluorescent findings and renal function.
Sinniah R; Feng PH
Clin Nephrol; 1976 Aug; 6(2):340-51. PubMed ID: 782752
[TBL] [Abstract][Full Text] [Related]
5. Characterization of C3 in C3 glomerulopathy.
Sethi S; Vrana JA; Fervenza FC; Theis JD; Sethi A; Kurtin PJ; Zhang Y; Smith RJH
Nephrol Dial Transplant; 2017 Mar; 32(3):459-465. PubMed ID: 27507892
[TBL] [Abstract][Full Text] [Related]
6. Membranoproliferative glomerulonephritis. Localization of early components of complement in glomerular deposits.
Davis BK; Cavallo T
Am J Pathol; 1976 Aug; 84(2):283-98. PubMed ID: 133617
[TBL] [Abstract][Full Text] [Related]
7. Localisation of complement components in association with glomerular extracellular particles in various renal diseases.
Nakajima M; Hewitson TD; Mathews DC; Kincaid-Smith P
Virchows Arch A Pathol Anat Histopathol; 1991; 419(4):267-72. PubMed ID: 1949609
[TBL] [Abstract][Full Text] [Related]
8. Immunoelectron microscopic studies of IgA nephropathy.
Doi T; Kanatsu K; Nagai H; Kohrogi N; Kuwahara T; Hamashima Y
Nephron; 1984; 36(4):246-51. PubMed ID: 6369162
[TBL] [Abstract][Full Text] [Related]
9. Composition of nephritic factor-generated glomerular deposits in membranoproliferative glomerulonephritis type 2.
West CD; Witte DP; McAdams AJ
Am J Kidney Dis; 2001 Jun; 37(6):1120-30. PubMed ID: 11382679
[TBL] [Abstract][Full Text] [Related]
10. Glomerulonephropathy with amyloid-stain-negative microfibrillar glomerular deposits.
Kobayashi Y; Fujii K; Kurokawa A; Kamiyama M; Miyazawa H
Nephron; 1988; 48(1):33-9. PubMed ID: 3277075
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical study of the membrane attack complex of complement in IgA nephropathy.
Miyamoto H; Yoshioka K; Takemura T; Akano N; Maki S
Virchows Arch A Pathol Anat Histopathol; 1988; 413(1):77-86. PubMed ID: 3131958
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis-B-associated glomerulonephritis: pathology, pathogenesis, and clinical course.
Venkataseshan VS; Lieberman K; Kim DU; Thung SN; Dikman S; D'Agati V; Susin M; Valderrama E; Gauthier B; Prakash A
Medicine (Baltimore); 1990 Jul; 69(4):200-16. PubMed ID: 2142748
[TBL] [Abstract][Full Text] [Related]
13. Immunofluorescence studies of dense deposit disease. The presence of railroad tracks and mesangial rings.
Kim Y; Vernier RL; Fish AJ; Michael AF
Lab Invest; 1979 Apr; 40(4):474-80. PubMed ID: 372673
[TBL] [Abstract][Full Text] [Related]
14. Electron microscopy and immunofluorescence of glomerular immune complex deposits in cancer patients.
Pascal RR; Iannaccone PM; Rollwagen FM; Harding TA; Bennett SJ
Cancer Res; 1976 Jan; 36(1):43-7. PubMed ID: 764968
[TBL] [Abstract][Full Text] [Related]
15. Glomerular complement components in human glomerulonephritis.
Verroust PJ; Wilson CB; Cooper NR; Edgington TS; Dixon FJ
J Clin Invest; 1974 Jan; 53(1):77-84. PubMed ID: 4586873
[TBL] [Abstract][Full Text] [Related]
16. Membranoproliferative glomerulonephritis with disruption of the glomerular basement membrane.
Strife CF; McEnery PT; McAdams AJ; West CD
Clin Nephrol; 1977 Feb; 7(2):65-72. PubMed ID: 844227
[TBL] [Abstract][Full Text] [Related]
17. Morphometric comparison of the quantity of the mesangial deposits in rebiopsied patients with idiopathic mesangial proliferative glomerulonephritis.
Danilewicz M; Wagrowska-Danilewicz M
Pathol Res Pract; 2001; 197(8):545-50. PubMed ID: 11518047
[TBL] [Abstract][Full Text] [Related]
18. Membranoproliferative glomerulonephritis in systemic sclerosis of childhood.
Waldherr R; Seelig HP; Klare B; Abigt J
Virchows Arch A Pathol Anat Histol; 1978 Aug; 379(2):169-79. PubMed ID: 150697
[TBL] [Abstract][Full Text] [Related]
19. Patient with diffuse mesangial and endocapillary proliferative glomerulonephritis with hypocomplementemia and elevated anti-streptolysin O treated with prednisolone, angiotensin-converting enzyme inhibitor, and angiotensin II receptor antagonist.
Ito S; Kuriyama H; Iino N; Iguchi S; Shimada H; Ueno M; Narita I; Nakano M; Nishi S; Karasawa R; Gejyo F
Clin Exp Nephrol; 2003 Dec; 7(4):290-5. PubMed ID: 14712359
[TBL] [Abstract][Full Text] [Related]
20. Histopathological manifestations of membranoproliferative glomerulonephritis and glomerular expression of plasmalemmal vesicle-associated protein-1 in a patient with polycythemia vera.
Nishi Y; Namikoshi T; Sasaki T; Tokura T; Nagasu H; Nakanishi H; Kozuka Y; Kashihara N
Clin Nephrol; 2010 Nov; 74(5):393-8. PubMed ID: 20979949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
